KIPS potential price per share valuation
600,000 cardiac by-pass op’s in the USA and Europe annually requiring an average of three of KIPS’s ‘meshes” so, 1.8 mm meshes but say 1/3 market share for 600,,000 meshes @ $1,200/mesh for revenue potential of $700 mm and a gross profit of $500 million.
Say, a 10 X multiple or $5 billion on, say, a doubled share count of 50 mm shares or a $100/sh potential value. Or, a maximum potential loss of $.70
This stock is severely undervalued and has a massive opportunity to run higher